Austin Health

Title
Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia.
Publication Date
2022-12
Author(s)
Hamilton, Garry W
Yeoh, Julian
Dinh, Diem
Reid, Christopher M
Yudi, Matias B
Freeman, Melanie
Brennan, Angela
Stub, Dion
Oqueli, Ernesto
Sebastian, Martin
Duffy, Stephen J
Horrigan, Mark
Farouque, Omar
Ajani, Andrew
Clark, David J
Subject
Outcomes
Percutaneous coronary intervention
Real-world
Safety
Stable ischaemic heart disease
Type of document
Journal Article
OrcId
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
DOI
10.1016/j.hlc.2022.08.019
Abstract
Percutaneous coronary intervention (PCI) in stable ischaemic heart disease (SIHD) has not been shown to improve prognosis but can alleviate symptoms and improve quality of life. Appropriately selected patients with symptoms refractory to medical therapy therefore stand to benefit, provided safety is proven.
Link
link
Citation
Heart, Lung & Circulation 2022; 31(12)
Jornal Title
Heart, Lung & Circulation
ISSN
1444-2892

Files:

NameSizeformatDescriptionLink